Seizures and risk of epilepsy in anti‐NMDAR, anti‐LGI1, and anti‐GABABR encephalitis
Annals of Clinical and Translational Neurology2020Vol. 7(8), pp. 1392–1399
Citations Over TimeTop 10% of 2020 papers
Chun‐Hong Shen, Gao‐Li Fang, Fan Yang, Meng‐Ting Cai, Yang Zheng, Wei Fang, Yi Guo, Yinxi Zhang, Meiping Ding
Abstract
Our study suggested that immunotherapy delay and IEDs were associated with the development of epilepsy in patients with anti-NMDAR, anti-LGI1, and anti-GABAB R encephalitis. Early diagnosis and treatment were required, and particular consideration should be given to patients with these risk factors.
Related Papers
- → Interleucinas na encefalopatia hipóxico-isquêmica(2003)14 cited
- Susquehanna Chorale Spring Concert "Roots and Wings"(2017)
- → Genentech taps Affimed’s antibodies(2018)
- Enxerto livre de arteria epigastrica inferior: avaliacao hemodinamica e angiografica pre e pos-operatoria(1988)
- → KOMPLIKASI REGIONAL ANESTESI PADA PEDIATRIK(2023)